...
首页> 外文期刊>Current Medicinal Chemistry >Synthesis, Biological Evaluation and 3D-QSAR of 1,3,5-Trisubstituted-4,5- Dihydro-(1H)-Pyrazole Derivatives as Potent and Highly Selective Monoamine Oxidase A Inhibitors
【24h】

Synthesis, Biological Evaluation and 3D-QSAR of 1,3,5-Trisubstituted-4,5- Dihydro-(1H)-Pyrazole Derivatives as Potent and Highly Selective Monoamine Oxidase A Inhibitors

机译:1,3,5-三取代-4,5-二氢-(1H)-吡唑衍生物作为强势和高选择性单胺氧化酶A抑制剂的合成,生物学评估和3D-QSAR

获取原文
获取原文并翻译 | 示例
           

摘要

The present report provides a extended study of the chemistry, the inhibitory activity against monoamino oxidases (MAO), and molecular modeling including the 3D-QSAR hypothesis of 1,3,5 - trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives.nnFour series of about eighty novel pyrazoline derivatives were prepared and investigated for their ability to inhibit the activity of the A and B isoforms of MAO selectively. Most of the new synthesized compounds proved more reversible, potent, and selective inhibitors of MAO-A than of MAO-B, and could be taken into account to develop the search further in this field, knowing that reversible and selective MAO-A inhibitors are used as antidepressant and antianxiety drug. The 30 most active compounds show inhibitory activity on MAO-A in the 8.6 x 10-8 - 9.0 x 10-9M range. Moreover, it should be pointed out that for most of them a high IC50 ≥ 10-9M value is associated with a high A-selectivity (Selectivity Index MAO-B/MAO-A in the 10,000 - 16,250 range). Furthermore, due to the presence of a chiral centre at the C5 position of the pyrazole moiety, we performed the semi-preparative chromatographic enantioseparation of the most potent, selective, and chiral compounds.nnThe separated enantiomers were then submitted to in vitro biological evaluation, and from the results of these experiments it has been possible to point out a difference in inhibiting the two isoforms selectively between the racemic mixture and the single enantiomers.nnThe molecular modeling work was carried out combining the Glide docking approach with CoMFA with the aim to rationalize the structure-activity relationships of each pyrazoline inhibitor toward MAO-A and MAO-B isoforms and to derive a suitable selectivity model.
机译:本报告提供了化学,对单氨基氧化酶(MAO)的抑制活性以及分子模型的扩展研究,包括1,3,5-三取代-4,5-二氢-(1H)-吡唑的3D-QSAR假设制备了大约八十种新型吡唑啉衍生物的四大系列,并研究了它们选择性抑制MAO的A和B异构体活性的能力。大多数新合成的化合物被证明比MAO-B具有更多的可逆,有效和选择性的MAO-A抑制剂,并且已知可逆和选择性的MAO-A抑制剂是可逆的和选择性的,因此可以考虑将其进一步发展。用作抗抑郁药和抗焦虑药。 30种活性最高的化合物在8.6 x 10-8-9.0 x 10-9M范围内对MAO-A表现出抑制活性。此外,应该指出的是,对于大多数传感器而言,高IC50≥10-9M值与高A选择性相关(选择性指数MAO-B / MAO-A在10,000-16,250范围内)。此外,由于在吡唑部分的C5位置存在手性中心,我们对最有效,选择性和手性化合物进行了半制备型色谱对映异构体分离。然后将分离出的对映异构体进行体外生物学评估,从这些实验的结果中,有可能指出在选择性抑制外消旋混合物和单一对映异构体之间的两种同工型方面的差异。nn进行了分子滑模对接和CoMFA结合的分子建模工作,目的是合理化每种吡唑啉抑制剂对MAO-A和MAO-B同工型的构效关系,并得出合适的选择性模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号